Sales and Marketing

Showing 15 posts of 11528 posts found.

Sun Pharma receives approval for first biologic drug

March 22, 2018 Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical

The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …

NICE turns down Dompe’s eye drops for rare eye condition over price concerns

March 21, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease

NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018 Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

Novartis steps into the medical marijuana business

March 20, 2018 Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical

Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …

Vertex “astonished” by NHS England’s response to CF drug

March 20, 2018 Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Male contraceptive pill hits safety goals

March 19, 2018 Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

“Game-changer” stem cell transplant shows strength in multiple sclerosis

March 19, 2018 Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma

A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …

Lundbeck takes risk on Parkinson’s treatment, €905m on table

March 19, 2018 Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …

India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust

March 19, 2018 Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma

India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018 Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy

March 16, 2018 Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …
The Gateway to Local Adoption Series

Latest content